Pharmaceutical formula for treating liver cirrhosis

Abstract

The present invention discloses a pharmaceutical formula for treating liver cirrhosis. The pharmaceutical formula for treating liver cirrhosis comprises the following components in weight ratios: 9-10g of radix bupleuri, 9 g of rhizoma pinelliae preparata, 9-12 g of radix scutellariae, 9-12 g of coptidis rhizoma, 12 g of radix codonopsis, 10-12 g of angelica sinensis, 10-12 g of radix paeoniae alba, 10-12 g of carapax trionycis preparata, 6-9 g of cortex magnoliae officinalis, 8-10 g of fructus psoraleae, 10-12 g of rhizoma atractylodis macrocephalae, 10-12 g of poria cocos, 9 g of honey-fried licorice root, 6 g of fresh ginger, 6 g of Chinese dates and 8-10 g of radix ophiopogonis. The pharmaceutical formula is suitable for treating liver cirrhosis and also solves a problem of large sideeffects of the existing drugs for treating liver cirrhosis. After years of clinical applications, symptoms of patients with liver cirrhosis are significantly improved and the quality of life is significantly improved.

Description

technical field [0001] The invention belongs to the technical field of formulations, and in particular relates to a pharmaceutical formulation for treating liver cirrhosis. Background technique [0002] Liver cirrhosis (liver cirrhosis LC) refers to the chronic progressive, diffuse, and fibrotic lesions of the liver caused by various reasons. It is one of the common chronic digestive system diseases in clinical practice and seriously endangers the health and life safety of patients. The onset of the disease is slow, the course of the disease is long, the incidence rate of men is higher than that of women, and it is more common in middle-aged and elderly men. If not treated in time, complications such as upper gastrointestinal bleeding, hepatic encephalopathy, and hepatorenal syndrome may occur. Liver cirrhosis can be divided into compensated phase and uncompensated phase. In the compensated phase, there is general imaging, biochemical or hematological examination evidence o...

AI Technical Summary

Problems solved by technology

However, most of the treatment measures are aimed at external pathogenic factors, ignoring the condition of the human body itself, and reluctantly applying western medicine to protect the liver and anti-virus drugs. Traditional Chinese medicine has important advantages in the treatment of liver cirrhosis, especially in improving the quality of life of patients and improving the clinical symptoms of patients. For patients who are elderly, physically weak, and suffer from other underlying diseases and cannot use certain therapeutic drugs, traditional Chinese medicine Treatment has unique advantages, thus the need for a drug formulation for the treatment of cirrhosis